-
Created 06 Sep 2026
Chronic Myeloid Leukemia in Low- and Middle-Income Countries: Increasing Access to Tyrosine Kinase Inhibitors and Supporting Treatment-Free Remission.
by Pat Garcia-Gonzalez, Colin Forsyth, Lauren Herzog, Alicia Annamalay, Jerald Radich — Clinical lymphoma, myeloma & leukemia. Aug 10, 2026.
- Views 0
- More stats
-
Created 06 Sep 2026
Nurses' Experiences of Caring for Children with Cancer: A Descriptive Phenomenological Study.
by Cânia Torres, Leonor Monteiro, Ana Sofia Pereira, Giovani Basso da Silva, Fernanda Carvalho, Paula Sousa — Seminars in oncology nursing. Pages 152357. Sep 05, 2026.
- Views 0
- More stats
-
Created 06 Sep 2026
Corrigendum to "The safety of extended dosing pembrolizumab when compared to traditional dosing: a review and meta-analysis of retrospective studies" [Lung Cancer 204 (2025) 108585].
by Prasanth Sekar, Ashmitha Ashok Kumar, Ian Hughes, Robert Mason, Marcin Dzienis — Lung cancer (Amsterdam, Netherlands). Pages 109598. Sep 05, 2026.
- Views 0
- More stats
-
Created 06 Sep 2026
Ultrasound Habitat Radiomics for Preoperative Prediction of Invasive Breast Cancer With a DCIS Component: A Dual-center Retrospective Study.
by Lifang Fan, Huazhang Wu, Yimin Wu, Shujian Wu, Chaoxue Zhang, Xiangming Zhu — Ultrasound in medicine & biology. Sep 05, 2026.
- Views 0
- More stats
-
Created 06 Sep 2026
Myositis with nemaline rods: Clinical features and treatment outcomes.
by Pitcha Chompoopong, Ikreet Cheema, Eileen Kokesh, Elie Naddaf — Journal of the neurological sciences. Volume 490: 126161. Sep 02, 2026.
- Views 1
- More stats
-
Created 06 Sep 2026
Structure-based design of a 1H-Tetrazole-containing scaffold for Caspase-1 inhibition: Synthesis, biological evaluation, and preliminary in Vivo studies.
by Ajay L Chandgude, Giovanni Loriga, Andrea Beccu, Fabio Arturo Iannotti, Ester Pagano, Raffaele Capasso, Riccardo Fusco, Pietro Spanu, Fausta Ulgheri, Alexander Domling — Bioorganic & medicinal chemistry. Volume 143: 118794. Sep 02, 2026.
- Views 0
- More stats
-
Created 06 Sep 2026
Prior Toll-like receptor 3 stimulation abolishes the ability of a MAPK/ERK kinase inhibitor to increase lipopolysaccharide-induced nitric oxide production concomitant with tumor necrosis factor-α suppression.
by Ryota Hashimoto, Yaojia Wu, Kaily Fujimoto, Haruto Shintani, Hiroshi Koide, Youichi Katoh — The Journal of pharmacology and experimental therapeutics. Volume 393(9): 105013. Aug 17, 2026.
- Views 0
- More stats
-
Created 06 Sep 2026
BE2012 a novel, REV-ERB antagonist that promotes regenerative myogenesis in vivo with substantially improved pharmacokinetics relative to SR8278.
by Isabelle Cote, Aurore C Valfort, Ryan K Sanders, Sheryl L Burris, Matthew E Hayes, Rhea Arya, Lingaiah Maram, Bahaa Elgendy, Feng Yue, Thomas P Burris — The Journal of pharmacology and experimental therapeutics. Volume 393(9): 105011. Aug 17, 2026.
- Views 1
- More stats
-
Created 06 Sep 2026
C12ORF54 mediates lipid droplet delivery to lysosomes with mutation causing childhood-onset metabolic dysfunction-associated steatotic liver disease.
by Ashish Negi, Abhishek Kumar, Yogendra Pratap Mathuria, Shailesh Kumar Gupta, Debasish Kumar Ghosh — Biochimica et biophysica acta. Molecular basis of disease. Volume 1873(1): 168453. Sep 05, 2026.
- Views 0
- More stats
-
Created 06 Sep 2026
Epidermal growth factor receptor-responsive supramolecular curcumin/carboxymethyl β-cyclodextrin self-assemblies enable improved treatment of triple-negative breast cancer.
by Irem Coksu, Pelin Pelit Arayici, Fatma Sayan Poyraz, Banu Mansuroglu, Serap Acar — Colloids and surfaces. B, Biointerfaces. Volume 269: 116119. Aug 29, 2026.
- Views 0
- More stats
Publications
Life Science Network features a scientific publication module you can use to share your research in life sciences and related disciplines. The module integrates post-publication review features. Publications can be uploaded or imported from PubMed.
For latest content published in some of the most popular scientific journals, check our Journal content module.
You can upload a publication here
Advertisement